Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
A patient who has already been on GLP-1 treatment through a compounding platform, is comfortable with the compounded medication model, and is looking for a continuation of that access pathway as the regulatory environment evolves
Unopened tirzepatide vials must remain refrigerated at 28C (3546F) until you begin injections
Patients should follow the instructions provided by their doctor
NICHOLAS P ALVAREZ (Chief Acquisition Officer) sold 75,000 shares for an estimated $443,760 ERIC HAROLD YECIES (Chief Legal Officer & GC) sold 15,000 shares for an estimated $183,750 To track insider transactions, check out Quiver Quantitative's insider trading dashboard
/assets/production/practices/3280152d22c7599df4208c7f13bd6f106ba2a939/images/2788239.jpeg)
About this article Cite this article Vidal, J., Flores, L., Jimnez, A
US$ 21.62
US$ 20.07
US$ 20.17
US$ 26.57
US$ 21.28
US$ 23.18
US$ 26.50
US$ 28.71
US$ 26.65
US$ 22.53
US$ 22.36
